The atypical chemokine receptor ACKR3 has recently been described to act as an opioid scavenger with exclusive damaging regulatory Attributes in the direction of different families of opioid peptides. In a very current research, we claimed the identification as well as the characterization of a different atypical opioid receptor https://www.proleviate.com/